Reactions Weekly

November 2019, Volume 1780, Issue 1, pp 120–120 | Cite as

Crizotinib/rifampicin interaction

Decrease in crizotinib plasma concentration: case report

Case report

First Online: 23 November 2019

• 49 Downloads

This is a preview of subscription content, log in to check access.

Reference

1. Chang C-H, et al. Rifampin may decrease the efficacy of crizotinib in lung cancer treatment. Kaohsiung Journal of Medical Sciences 35: 580-581, No. 9, Sep 2019. Available from: URL: http://doi.org/10.1002/kjm2.12078 - TaiwanCrossRefGoogle Scholar

Copyright information

© Springer International Publishing AG 2019